Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #36825 on Anavex Life Sciences Corp (AVXL)
hooperg83
11/15/15 8:25 PM
#36831 RE: orveko_inc #36825
stealthways
11/16/15 9:25 AM
#36896 RE: orveko_inc #36825
Basically, A2-73's agonism of sigma-1 and M1 receptors may work to alter the progression of AD, while its antagonism of the M2 and M3 receptors may work to improve the affects of donepezil on the symptoms of the disease.